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ABSTRACTSResults: MRI identiﬁed 23 desmoids in 9 patients – 9 intra-abdominal
desmoids (IAD), 10 abdominal wall desmoids (AWD) and four extra-
abdominal desmoids (EAD). CT only identiﬁed 21 desmoids – one EAD
and one AWD were not identiﬁed. The two modalities were equivalent
in terms of deﬁning local extent of desmoid. There was no difference in
median desmoid size – 56.7 (range 2-215) cm2 on MDCT and 56.3(3-
215) cm2 on MRI (p¼0.985). The mean MRI-ER – 1.12 (standard devi-
ation 0.43) – was greater than CT-ER – 0.48(0.16) (p<0.0001). High
signal intensity on T2-MRI was associated with increased MR-ER
(p¼0.006).
Conclusions:MRI is superior toMDCT for the detection of desmoids in FAP.
Coupled with the advantage of avoiding radiation, it should be considered
as the primary imaging modality for young FAP patients.
ASIT MEDAL 0853: A RANDOMIZED CONTROLLED TRIAL EVALUATING
ENDOSCOPIC AND LAPAROSCOPIC TRAINING IN SKILLS TRANSFER
FOR NOVICES PERFORMING A SIMULATED NOTES TASK
Jean Nehme, Mikael Sodergren, Colin Sugden, Raj Aggarwal, Sonja
Gillen, Hubertus Feussner, Guang-Zhong Yang, Ara Darzi. Imperial
College, London, UK
Background: The NOSCAR white paper lists training as an important step
to the safe clinical application of NOTES. The aim of this randomized-
controlled-trial was to evaluate whether training novices in a laparoscopic
or endoscopic simulator-curriculum would affect performance in a NOTES
simulator-task.
Methods: Thirty novices were randomized to three-groups: no-training
(n¼10), endoscopy-training (n¼10), and laparoscopy-training (n¼10). All
participants completed a simulated-NOTES-task on the ELITE (Endoscopic-
Laparoscopic Interdisciplinary Training Entity) model. Performance was
assessed as time taken to complete individual-steps, overall-task time and
number of errors.
Results: The endoscopy-group was signiﬁcantly faster than the control-
group at accessing the peritoneal cavity (median 27 versus 78 sec;
p¼0.015), applying diathermy to the appendix (median 103.5 versus 173
sec; p¼0.014), and navigating to the gallbladder (median 76 versus 169.5
sec; p¼0.049). Endoscopy participants completed the full NOTES proce-
dure in a shorter time than the laparoscopy group (median 863 versus
2074 sec; p<0.001).
Conclusion: This highlights the importance of endoscopic-training for
a simulated NOTES task that involves both navigation and resection with
operative maneuvers. Although laparoscopic training confers some beneﬁt
for operative steps such as applying diathermy to the gallbladder fossa, this
was not as beneﬁcial as training in endoscopy.
ASIT MEDAL 0868: THE DEVELOPMENT OF A NOVEL TENDON
AUGMENTATION GRAFT
Zafar Ahmad, John Wardale, Roger Brookes, Neil Rushton. University of
Cambridge, Cambridge, UK
Introduction: Rotator cuff tears remain a problem, with massive rotator
cuff tears having a failure rate of repair of up to 90%, despite new surgical
techniques. Tissue engineering techniques offer the possibility of gener-
ating pre-injury tendon tissue. We present the development of a novel
tendon augmentation graft made of extruded collagen graft used with
tissue engineering techniques to overcome this challenge.
Methods: In-vitro: Sheep tenocytes were placed on the augmentation
graft with and without Platelet Rich Plasma (PRP). An evaluation of
collagen production, cell proliferation, and cell adherence of the material
was done over a 3 week period.
In-vivo: 24 sheep were operated on with the detachment and reattach-
ment of the infraspinatus of the sheep. The repair groups were divided as
follow: (1) Control (2) Extruded collagen graft (3) Biphasic collagen scaf-
fold (4) Biphasic collagen scaffold with platelet rich plasma. The sheep
were harvested at 12 weeks.
Results: In-vitro: The sheep tenocytes are indeed able to adhere,
proliferate on the novel material. However the use of platelet rich
plasma has lead to an even higher level of cell proliferation and collagen
production
In-vivo: The outcomes show that the material integrated and enhanced
the tendon repair. Immunohistochemistry will be presented.ASIT MEDAL 1122: EXPRESSION OF TOTAL VASCULAR ENDOTHELIAL
GROWTH FACTOR (VEGF) AND INHIBITORY ISOFORMS OF VEGF IN
HEAD AND NECK SQUAMOUS CELL CARCINOMA
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3Department of Molecular and Clinical Cancer Medicine, University of
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Aims: Angiogenesis is an absolute requirement for tumour survival and
progression, of which vascular endothelial growth factor-A (VEGF-A) is
a potent stimulator. Alternative splicing, however, results in a family of
highly anti-angiogenic endogenous sister isoforms (VEGFxxxb), not yet
investigated in head and neck squamous cell carcinoma (HNSCC). We
investigated whether VEGF isoform expression was altered in HNSCC and
compared this with clinicopathological outcomes.
Methods: Ninety-three HNSCCs (29 larynx, 38 oropharynx, 26 hypo-
pharynx) were studied. Tumour sections were assessed by immunohis-
tochemistry with total VEGF (panVEGF) and VEGFxxxb-speciﬁc antibodies,
and analysed by 2 assessors (blinded).
Results: PanVEGF expressionwas signiﬁcantly reduced in hypopharyngeal
tumours (ANOVA p<0.01) and was signiﬁcantly associated with increasing
T stage in laryngeal tumours but not for other sites (p<0.05). Signiﬁcant
correlations were demonstrated for panVEGF and VEGFxxxb:panVEGF
expressions and length of overall survival (p<0.05 and p<0.0001, Pearson).
No signiﬁcant differences were demonstrated in panVEGF, VEGFxxxb, or
expression ratio (VEGFxxxb:panVEGF) when correlated for presence of
lymph node metastasis, extra-capsular spread, vascular invasion, or
recurrence.
Conclusions: Total VEGF expression appears upregulated in HNSCC,
particularly in advanced laryngeal tumours. Increased relative expression
of inhibitory VEGF isoforms may be a biological marker of enhanced
survival and merits further large-scale investigation.
ASIT MEDICAL STUDENT PRIZE: 0220 WINNER OF ASIT MEDICAL
STUDENT PRIZE: ASSESSMENT OF PERIOSTIN AND TRANSGLUTAMINASE
2 AS POTENTIAL BIOMARKERS IN OESOPHAGEAL ADENOCARCINOMA
Chukwudi Trevor Uzoho, Fergus Noble, Andrew Bateman, Mattheiu
Derouet, Tim Underwood. University of Southampton, Southampton, UK
Aim: To model biomarker identiﬁcation, we evaluated POSTN and TG2 as
they have been shown in various cancers to correlate with cell survival,
invasion, and resistance to chemotherapy.
Methods: Using primary OAC tissue (chemotherapy responders ((TRG
1-3), n¼30), non-responders ((TRG 4-5) n¼30), and chemonaive (n¼30; 8
matched normal oesophagus, 6 metastatic lymph nodes)) protein
expression of TG2 and POSTN was assessed by immunohistochemistry
(weakly positive (0-5%), positive (5-50%) and strongly positive (50-100%))
and correlated to clinicopathological data.
Results: POSTN and TG2was positive or strongly positive in 90% and 76% of
OAC tumour compared to only 13% and 13% being positive in matched
normal oesophagus (p¼0.015, p¼0.009). POSTN is expressed at a higher
level in non-responders compared to responders (p¼0.014) as well as TRG
(p¼0.040). Low levels of POSTN expression (0-5%) correlates with
improved survival.
Conclusion: The positive expression of POSTN and TG2 in oesophageal
cancer with limited expression in normal oesophageal tissue suggests
a functional role in OAC and provides biomarker potential. The signiﬁcant
correlation of POSTN with TRG suggests POSTN may be clinically useful in
predicting response to neoadjuvant chemotherapy.
ASIT MEDICAL STUDENT PRIZE: 0226: A GENERATION OF
LAPAROSCOPIC NEPHRECTOMY: STAGE SPECIFIC SURGICAL AND
ONCOLOGICAL OUTCOMES FOR LAPAROSCOPIC NEPHRECTOMY IN
A SINGLE CENTRE
Alexander Laird, Grant Stewart, Jim Zhong, Jensen Ang, Antony
Riddick, David Tolley, Alan McNeill. University of Edinburgh, Edinburgh, UK
Introduction/Aims: To determine the stage-speciﬁc operative, post-
operative and oncological outcomes, for patients undergoing
